Lodha Group aims carbon neutrality in operations by 2035

Group, also known as Macrotech Developers, is looking to go carbon neutral by 2035 with the help of road-mapping exercises done with Rocky Mountain Institute (RMI) that had also advised Lodha in the sustainability planning of their flagship Palava city project.

The country’s largest real estate developer, in terms of residential sales, will undertake the entire process in two phases. The first phase will prioritize emissions from owned sources including company facilities and vehicles and generated from purchased energy, the second phase is going to address indirect emissions occurring in the value chain, such as tenant energy, transportation, and embodied carbon.

“Over the past few years, climate change and sustainable development have become ever contextual. So, it is important to develop the right perspective towards climate change, and the significant transition and physical risks that global warming confronts us with. We have realized that we have a much larger responsibility as a leading player and we have been setting benchmarks for high quality and sustainable developments, across price segments in India,” said Abhishek Lodha, MD & CEO, Lodha Group.

The company is establishing a North Star goal of carbon neutrality in its operations by 2035, adhering to an internationally recognized commitment framework.

“RMI and RMI India are dedicated to their mission of responsibly and cost-effectively decarbonizing buildings by 2050. We are consistently collaborating with Governments, and business leaders on several projects to enable a low carbon future for India,” said RMI spokesperson, Victor Olgyay.

Lodha, under the guidance of RMI, has formulated a broad scope for sustainability, encompassing energy efficiency, energy procurement, embodied carbon, waste, water, and transportation. Successful pilot projects will provide opportunities to scale up feasible solutions and achieve significant emission reductions for the overall buildings’ portfolio.

See also  Glenmark Pharma says USFDA has issued CRL for Ryaltris

With the fast-paced growth of the real estate sector, green and sustainable developments are witnessing an increasing demand.



Please enter your comment!
Please enter your name here